Hims & Hers Health (HIMS) stock has jumped up upon the telehealth provider introducing compounding injectable GLP-1 weight-loss drugs to its services. Yahoo Finance's Jared Blikre and Julie Hyman report on Hims & Hers' latest offering in the weight-loss drug category.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination.

This post was written by Luke Carberry Mogan and updated by Melanie Riehl